Skip to main content

Funding Opportunities

Funding

Division of Infectious Diseases Emerging and Re-Emerging Pathogens Program (EREPP): 2022 Call for Proposals

Issued: August 19, 2022

Application Due Date: September 23, 2022

Projected Award Start Date: November 1, 2022

 The Emerging and Re-emerging Pathogens Program (EREPP) requests applications to support research proposals focused on emerging and re-emerging infections as well as infrastructure proposals focused on the attainment of equipment that will have a lasting impact and bring new capabilities to an existing research program in infectious diseases. Applications may request support for basic, translational, or clinical research and should represent a new project that is distinct from any currently funded research. Areas of special interest include COVID-19, Monkeypox virus, and antimicrobial resistance.

Eligibility requirements: Applicants must hold a rank of Assistant Professor (including Research Assistant Professors) or higher. At least one co-investigator must hold a primary appointment within the Division of Infectious Diseases in the Feinberg School of Medicine. Preference will be given to collaborative projects and those that involve junior faculty.

 

Research Proposals

    Budget: A maximum of $40,000 (direct costs only).

    Duration: A maximum of 12 months.

    Application procedure: Please submit a three-page overview of the project that includes the investigative team, the budget, a description of the research project aims (including its relevance to emerging and re-emerging infections), a statement on how the project differs from the established and ongoing research performed by the group, projected timeline (accounting for IRB approval), and plans for how the award will lead to additional funding.

    Anticipated awards: 3-4

 

Infrastructure Proposals

    Budget: A maximum of $25,000 (direct costs only, no funds for reagents or service plans).

    Application procedure: Please submit a three-page overview of the requested infrastructure investment that includes the investigative team and projected users, the budget, a description of the equipment, a description of the new research that the equipment will enable (including its relevance to emerging and re-emerging infections), and an access/maintenance plan. Applicants must provide a quote for the requested equipment at the time of submission.

    Anticipated awards: 2

 

Submission Instructions: Please submit applications as a single PDF file directly to the EREPP Director, Dr. Judd Hultquist, by e-mail at judd.hultquist@northwestern.edu. Submissions will close on Friday, September 23 at 5:00pm Central time. Applications will be reviewed by an independent panel of investigators.

For questions, please contact EREPP Director, Dr. Judd Hultquist (judd.hultquist@northwestern.edu).

Previous EREPP Pilot Grant Awardees and Accomplishments

Chad Achenbach, MD (Department of Medicine, Division of Infectious Diseases) for the study of “COVID-19 presentation, testing, treatment and outcomes at Northwestern Medicine,” $30,000.

Pablo Penaloza, PhD (Department of Microbiology-Immunology) and Judd Hultquist, PhD (Department of Medicine, Division of Infectious Diseases) for the study of “Elucidating immunological parameters associated with recovery from COVID-19 disease,” $50,000.

Huiping Liu, MD, PhD (Department of Pharmacology), Deyu Fang, PhD (Department of Pathology), Michael Ison, MD (Department of Medicine, Division of Infectious Diseases), and Suchitra Swaminathan, PhD (Department of Medicine, Division of Rheumatology) for the study of “Generation of human monoclonal antibody neutralizing SARS-CoV-2 using patient B cells,” $50,000.

Eun-Young Kim, PhD and Steven Wolinsky, MD (Department of Medicine, Division of Infectious Diseases) for the study of “Pathogenesis in the nonhuman primate model for SARS-CoV-2,” $40,000.